America’s biopharmaceutical industry is willing to work with all stakeholders to deliver a stronger, more resilient, affordable and equitable health care system for all. Common-sense, patient-centered reforms built on three core goals will help ensure everyone benefits from America’s engine of innovation and gets the care they need and deserve.